bioRxiv Science⌕ Search

Biology subjects

Vig, E.

Publications and source records attributed to Vig, E..

3 recordsLinked to original sources

Mechanistic Dissection of Entropic Penalty upon Ligand Binding and Molecular Flexibility via Molecular Dynamics Simulations and Machine Learning

Molecular flexibility governs how molecules behave, reorganize, and respond to their environment. Although experiments measure molar entropy for small molecules and molecular dynamics (MD) simulations capture molecular motions, quantifying configuration entropy and the concerted internal motions such as torsion rotations, angle bending, and their couplings are central to understanding thermodynamic behavior but remains challenging. To dissect these contributions, we used MD trajectories and developed an internal coordinate PC-entropy (iPC-entropy) method to probe the origins of entropy and reveal how specific motions shape the thermodynamic landscape. The studies accurately captured molar entropy, identified key torsional motions as major contributors, and uncovered a critical angle-torsion coupling in which angle bending was strongly correlated with torsional rotation, a coupling that increases nonlinearly with molecular size. Evaluating entropic changes upon protein-ligand binding reveals that dominant entropic penalty arises from ligand dihedral rigidification rather than protein reorganization and highlights the specific dihedral rotations that become restricted. We also suggest systematic corrections for approaches considering solely rotamers to reliably reproduce the relative entropic penalty in computer-aided drug discovery. Together, our findings elucidate the molecular origins of entropy and entropy changes. In addition, we can quantify and illustrate the internal motions that strongly shape binding thermodynamics, thereby offering mechanistic insights to guide drug development.

biophysics↗

Revealing imatinib-kinase specificity via analyzing changes in protein dynamics and computing molecular binding affinity

Drug promiscuity is a double-edged sword where a small molecule acts on multiple biological targets to induce toxicological or therapeutic benefits. It is possible to exploit promiscuity to expand treatment options without the prohibitive costs of designing a new drug. Imatinib is a representative case, exhibiting varied affinities and inhibitions to different kinases. It binds most favorably to Abl and Kit kinases, intermediately to Chk1 and Lck kinases, and least favorably to p38 and Src kinases. The strongly conserved features of the ATP-binding site render imatinibs molecular binding determinants unclear despite over 25 years of interrogation. To address this question, molecular thermodynamics, force distribution analysis, residue sidechain dihedral correlations, and principal component analysis were computed using trajectories from all-atom molecular dynamics simulations in explicit solvent. The results of these simulations agree with experimental affinity and binding data, enabling highly predictive factors for imatinibs binding specificity from free- and bound-state simulations through a global protein network of protein-ligand interactions, changes in sidechain dihedral correlations, and shifts in the secondary motifs modulating binding site access corresponding with well-characterized kinase "breathing motions." The sidechain dihedral correlation network also identifies distal mutants known to reduce patients imatinib sensitivity. Higher imatinib-kinase affinity trends with a loss in sidechain dihedral correlations and diminished secondary motif migration following binding, corresponding with more restricted configurations, to reduce solvent approach and ATP competition. Lower-affinity proteins show enhanced sidechain dihedral correlation and exaggerated secondary motif motions. This is consistent with a tendency to expose the protein pocket, facilitate solvent entrance, and increase ATP competition. Using imatinib as a model system, this study shows residue correlation, force interaction, and essential principal components can effectively forecast imatinib-kinase binding specificity and introduces an effective approach to repurpose and design high-affinity binders for off-target applications more generally.

biochemistry↗

Pathway Specific Unbinding Free Energy Profiles of Ritonavir Dissociation From HIV-1 Protease

Investigation of protein-drug recognition is key in understanding drug selectivity and binding affinity. In combination, binding/unbinding free energy landscape and intermolecular interactions can be used to understand the drug binding/unbinding mechanisms. This information is vital for the development of drugs with improved efficacy and explanation of mutation effects. This study investigated the dissociation processes of ritonavir unbinding from HIV protease (HIVp). Analyzing unbinding trajectories modeled by accelerated molecular dynamics (MD) simulations, three distinct pathways, Pathways A, B, and C, were characterized. Using reduced dimensionality strategy with the principal component analysis, we carried out short classical MD runs with explicit water to sample local fluctuation during ritonavir dissociation and applied the milestoning theory to construct unbinding free energy landscape. We found that each pathway showed similar values of binding free energy, albeit Pathway A accounts for over 50 percent of dissociation trajectories. Interesting, residue-residue correlation network analysis showed that in Pathway A, a broad correlation network outside the flap region governs protein motions during ritonavir unbinding which includes residues with reported mutation effects. However, the other two pathways showed limited correlation networks where no reported mutated residues were involved, explaining the favorability of Pathway A. Guided by the free energy profile, we investigated how and why of an energy barrier and minimum and demonstrated that hydrogen bonding governed the movement of the flap regions, directly impacting the calculated energy. Our study provided a new strategy to estimate ligand binding free energy and demonstrated the importance of the transient interactions during ligand-protein dissociation pathways in understanding drug unbinding.

biochemistry↗